Typicality: | 0.368 |
Saliency: | 0.277 |
in both these trials | 2 | temporal |
under a contract | 2 | other |
vaccine → be manufactured by → sanofi pasteur | 7 |
vaccine → be produced by → sanofi pasteur | 6 |
vaccine → be made by → sanofi pasteur | 6 |
vaccine → be developed by → sanofi pasteur | 4 |
negative | neutral | positive |
0.132 | 0.784 | 0.084 |
Raw frequency | 23 |
Normalized frequency | 0.277 |
Modifier score | 0.500 |
Perplexity | 41.127 |